Literature DB >> 16511236

Crystallization and diffraction properties of the Fab fragment of 3B5H10, an antibody specific for disease-causing polyglutamine stretches.

Clare Peters-Libeu1, Yvonne Newhouse, Preethi Krishnan, Kenneth Cheung, Elizabeth Brooks, Karl Weisgraber, Steven Finkbeiner.   

Abstract

Because it binds soluble forms of proteins with disease-associated polyglutamine expansions, the antibody 3B5H10 is a powerful tool for studying polyglutamine-related diseases. Crystals of the 3B5H10 Fab (47 kDa) were obtained by vapor diffusion at room temperature from PEG 3350. However, the initial crystals gave highly anisotropic diffraction patterns. After optimization of the crystallization conditions and cryoprotectants, a nearly isotropic diffraction pattern at 2.6 A resolution was achieved for crystals with unit-cell parameters a = 133.26, b = 79.52, c = 41.49 A and space group P2(1)2(1)2. Dehydrated crystals diffracted isotropically to 1.9 A with unit-cell parameters a = 123.65, b = 78.25, c = 42.26 A, beta = 90.3 degrees and space group P2(1).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16511236      PMCID: PMC1978161          DOI: 10.1107/S1744309105036547

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  12 in total

1.  Using antibodies to analyze polyglutamine stretches.

Authors:  Elizabeth Brooks; Montserrat Arrasate; Kenneth Cheung; Steven M Finkbeiner
Journal:  Methods Mol Biol       Date:  2004

2.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.

Authors:  Montserrat Arrasate; Siddhartha Mitra; Erik S Schweitzer; Mark R Segal; Steven Finkbeiner
Journal:  Nature       Date:  2004-10-14       Impact factor: 49.962

Review 3.  Molecular genetics of Huntington's disease.

Authors:  M E MacDonald
Journal:  Results Probl Cell Differ       Date:  1998

4.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

5.  High-resolution crystals of methionine aminopeptidase from Pyrococcus furiosus obtained by water-mediated transformation.

Authors:  T H Tahirov; H Oki; T Tsukihara; K Ogasahara; K Yutani; C P Libeu; Y Izu; S Tsunasawa; I Kato
Journal:  J Struct Biol       Date:  1998-01       Impact factor: 2.867

6.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.

Authors:  E Scherzinger; A Sittler; K Schweiger; V Heiser; R Lurz; R Hasenbank; G P Bates; H Lehrach; E E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 7.  Glutamine repeats and neurodegeneration.

Authors:  H Y Zoghbi; H T Orr
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

Review 8.  Huntington's disease: the challenge for cell biologists.

Authors:  A J Tobin; E R Signer
Journal:  Trends Cell Biol       Date:  2000-12       Impact factor: 20.808

9.  Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

Authors:  S W Davies; M Turmaine; B A Cozens; M DiFiglia; A H Sharp; C A Ross; E Scherzinger; E E Wanker; L Mangiarini; G P Bates
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

10.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.

Authors:  M F Perutz; T Johnson; M Suzuki; J T Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

View more
  14 in total

1.  Disease-associated polyglutamine stretches in monomeric huntingtin adopt a compact structure.

Authors:  Clare Peters-Libeu; Jason Miller; Earl Rutenber; Yvonne Newhouse; Preethi Krishnan; Kenneth Cheung; Danny Hatters; Elizabeth Brooks; Kartika Widjaja; Tina Tran; Siddhartha Mitra; Montserrat Arrasate; Luis A Mosquera; Dean Taylor; Karl H Weisgraber; Steven Finkbeiner
Journal:  J Mol Biol       Date:  2012-01-28       Impact factor: 5.469

2.  IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome.

Authors:  Leslie Michels Thompson; Charity T Aiken; Linda S Kaltenbach; Namita Agrawal; Katalin Illes; Ali Khoshnan; Marta Martinez-Vincente; Montserrat Arrasate; Jacqueline Gire O'Rourke; Hasan Khashwji; Tamas Lukacsovich; Ya-Zhen Zhu; Alice L Lau; Ashish Massey; Michael R Hayden; Scott O Zeitlin; Steven Finkbeiner; Kim N Green; Frank M LaFerla; Gillian Bates; Lan Huang; Paul H Patterson; Donald C Lo; Ana Maria Cuervo; J Lawrence Marsh; Joan S Steffan
Journal:  J Cell Biol       Date:  2009-12-21       Impact factor: 10.539

3.  A compact beta model of huntingtin toxicity.

Authors:  Qi Charles Zhang; Tzu-Lan Yeh; Alfonso Leyva; Leslie G Frank; Jason Miller; Yujin E Kim; Ralf Langen; Steven Finkbeiner; Mario L Amzel; Christopher A Ross; Michelle A Poirier
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

4.  Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein.

Authors:  Leslie G Nucifora; Kathleen A Burke; Xia Feng; Nicolas Arbez; Shanshan Zhu; Jason Miller; Guocheng Yang; Tamara Ratovitski; Michael Delannoy; Paul J Muchowski; Steven Finkbeiner; Justin Legleiter; Christopher A Ross; Michelle A Poirier
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

Review 5.  Protein aggregates in Huntington's disease.

Authors:  Montserrat Arrasate; Steven Finkbeiner
Journal:  Exp Neurol       Date:  2011-12-19       Impact factor: 5.330

Review 6.  Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.

Authors:  Adewale Adegbuyiro; Faezeh Sedighi; Albert W Pilkington; Sharon Groover; Justin Legleiter
Journal:  Biochemistry       Date:  2017-02-21       Impact factor: 3.162

7.  Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment.

Authors:  Justin Legleiter; Gregor P Lotz; Jason Miller; Jan Ko; Cheping Ng; Geneva L Williams; Steve Finkbeiner; Paul H Patterson; Paul J Muchowski
Journal:  J Biol Chem       Date:  2009-06-02       Impact factor: 5.157

8.  Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity.

Authors:  Yoko Nekooki-Machida; Masaru Kurosawa; Nobuyuki Nukina; Kazuki Ito; Toshiro Oda; Motomasa Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

9.  Formation and toxicity of soluble polyglutamine oligomers in living cells.

Authors:  Patrick Lajoie; Erik Lee Snapp
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

10.  Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease.

Authors:  Kirupa Sathasivam; Amin Lane; Justin Legleiter; Alice Warley; Ben Woodman; Steve Finkbeiner; Paolo Paganetti; Paul J Muchowski; Stuart Wilson; Gillian P Bates
Journal:  Hum Mol Genet       Date:  2010-01-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.